Cellular Health Screening Market 2023 Challenges, Import Export Consumption, Demand and Forecast 2030
The global cellular health screening market size was valued at USD 2.78 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030.
Over the projected period, the importance of precision medicine is expected to increase along with the requirement to analyze biomarkers for aging and cellular health in general. In addition, cellular health screening plays a crucial role in monitoring the body’s reaction to treatment regimens, which is anticipated to contribute to the growth of the market. Companies involved in delivering cellular health screening goods and services noticed a reduction in their sales and base testing volume as a result of the COVID-19 pandemic.
In addition to the pandemic-related mandates by the government, the transportation restrictions and limitations on the import and export of raw materials and goods disrupted the supply chain. Owing to the decrease in demand as a result of supply chain disruption, many businesses have broadened their product lines to include COVID-19 molecular and antibody testing, which can equally counterbalance the decline in base testing volume.
Gather more insights about the market drivers, restrains and growth of the Cellular Health Screening Market
The use of home diagnostic tests is significantly rising globally. The growing number of campaigns to educate the public about the signs of chronic diseases and how to prevent them in order to contain disease epidemics are expected to fuel growth. As a result, there is a significant demand for cellular health screening kits and services due to greater patient awareness. Additionally, the use of these devices helps to optimize prompt treatment decisions, increases the effectiveness of care given, and dramatically lowers diagnosis costs, especially in resource-constrained countries with inadequate laboratory facilities.
Numerous studies have shown a connection between malignancies and telomere length. Telomere shortening as a tumor suppressor turns out to be a significant factor in cancer that has progressed more severely. Although it has been demonstrated that a range of variables, including infections, inflammation, and stress, affect the length of telomeres and inflammation, in particular, causes oxidative stress, which, in turn, causes telomere erosion. According to research, telomere maintenance plays a significant role in how aging and related disorders are affected by environmental, lifestyle, and genetic factors. As a result, it is crucial to know how quickly telomeres change in order to understand biological aging and hereditary illnesses. Furthermore, telomere length loss has been linked to pathologies associated with aging, including cancer, cardiovascular illnesses, and weakened immune systems. The need for cellular health screening is projected to grow over the years with the rising incidence of chronic diseases, which further drives the market.
Growing awareness campaigns by numerous organizations throughout the world have played a significant role in increasing the demand for testing-based preventive healthcare products and services. One of the key factors anticipated to drive the market during the forecast period is collaborative efforts by organizations such as the CDC, the U.S. Preventive Services Task Force (USPSTF), the National Cervical Cancer Coalition, and the WHO.
In addition, major industry companies are launching campaigns to raise awareness about cervical and vaginal cancer screening to prevent mortality. For instance, as per the article published by theguardian.com, in February 2022, an awareness campaign has been launched in England to increase life-saving screening. This campaign was launched by the Department of Health and Social Care.
Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
- The global point of care infectious disease testing market size was valued at USD 11.40 billion in 2023 and is projected to grow at a CAGR of 4.3% from 2024 to 2030.
- The global transplant diagnostics market size was valued at USD 5.97 billion in 2023 and is projected to grow at a CAGR of 7.3% from 2024 to 2030.
Cellular Health Screening Market Segmentation
Grand View Research has segmented the global cellular health screening market on the basis of test type, sample type, collection site and region:
Cellular Health Screening Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Single Test Panels
- Telomere Tests
- Oxidative Stress Tests
- Inflammation Tests
- Heavy Metals Tests
- Multi-test Panels
Cellular Health Screening Sample Type Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Serum
- Urine
Cellular Health Screening Collection Site Outlook (Revenue, USD Million, 2018 - 2030)
- Home
- Office
- Hospital
- Diagnostic Labs
Cellular Health Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait
Key Companies profiled:
- Life Length
- SpectraCell Laboratories, Inc.
- RepeatDx
- Cell Science Systems
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- OPKO Health, Inc.
- Genova Diagnostics (GDX)
- Immundiagnostik AG
- DNA Labs India
Order a free sample PDF of the Cellular Health Screening Market Intelligence Study, published by Grand View Research.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Игры
- Gardening
- Health
- Главная
- Literature
- Music
- Networking
- Другое
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian